Sort
48,018 grants matching “immunotherapy”
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$739,630James D. Marks · University Of California, San Francisco · U01 · FY2011 · AI
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients
$739,566Zhongxing Liao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · HL
Refining Immune Heterogeneity in Pediatric Sepsis Multiple Organ Dysfunction Syndrome
$739,487Kenneth Eugene Remy · Case Western Reserve University · R01 · FY2025 · HD
PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments
$739,484Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2025 · CA
Personalized vaccine for patients with AML
$739,429David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
Lung Cancer Care Outcomes/Surveillance Consortium-Iowa
$739,307University Of Iowa · U01 · FY2005 · CA
PTPN22 R619W in NOD mice
$739,100Linda A Sherman · Scripps Research Institute, The · R56 · FY2016 · AI
Project 1 - Clinical Trial
$738,729Andrew R Haas · University Of Pennsylvania · P01 · FY2019 · CA
CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHL
$738,698Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$738,657Jyothi Rengarajan · Emory University · R01 · FY2019 · AI
Monitoring Autophagy in the Heart and in Tumors Treated with Potentially Cardiotoxic Chemotherapy
$738,627Howard H. Chen · Tufts Medical Center · R01 · FY2025 · HL
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
$738,581James Even Voss · Scripps Research Institute, The · R01 · FY2023 · AI
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$738,543Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2016 · NR
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$738,484William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
NextGen - CRI
$738,441Catherine Mary Bollard · Children'S Research Institute · OT2 · FY2023 · CA
HBV-specific T cell immunity in HBV/HIV coinfection
$738,419Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R37 · FY2023 · AI
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$738,317Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Combination host-directed and antibacterial therapy for pulmonary intracellular infections
$738,160Patrick S. Stayton · University Of Washington · R01 · FY2024 · AI
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging
$738,039Matthew Spitzer · University Of California, San Francisco · R01 · FY2025 · DE
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$738,015James Bruce Pitner · Nirvana Sciences, Inc. · R42 · FY2016 · AI
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism
$737,997Joren C Madsen · Massachusetts General Hospital · P01 · FY2024 · HL
Lysis-free extraction of biopharmaceuticals from the periplasm of Clean Genome E. coli
$737,950Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2020 · AI
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$737,882Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY
$737,794Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA
Senior Leaders
$737,786Judith Cheryl Gasson · University Of California Los Angeles · P30 · FY2009 · CA